Dynamk Capital LLC

10/16/2024 | Press release | Archived content

Lucid Scientific Highlighted by Memorial Sloan Kettering Cancer Center in The Scientist

In this latest issue of The Scientist, portfolio company Lucid Scientific's Recipher Platform is highlighted by researchers at Memorial Sloan Kettering Cancer Center as a novel way to measure live oxygen consumption rate (OCR) in cell culture. OCR, and more specifically the amount of oxygen available at the cells is a critical parameter Lucid's technology provides.

Dynamk Capital LLC published this content on October 16, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 06, 2026 at 12:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]